Wart treatment with sclerotherapy and candida antigen
Part of Infections, Skin clinical trials.
This study tests two treatments for common warts: sclerotherapy (injecting a solution into the wart to cut off its blood supply) and candida antigen (a yeast extract that boosts the immune system to fight the wart). It aims to see if these treatments are safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be older than 18 years.
- You must have a common wart that has been confirmed by a doctor.
- You cannot have received any wart treatment in the last month.
- You cannot have kidney or liver disease.
- You cannot be pregnant or breastfeeding.
- You cannot be on immunosuppressive therapy (medicines that weaken the immune system).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two versions of an at-home medicine to see how well they clear warts. Participants are randomly assigned to the study medicine or a placebo (inactive treatment) so researchers can compare results fairly.
This trial tests two injected treatments (vitamin D3 or acyclovir) for common skin warts. The goal is to see which one works better for warts that are new or have not gone away with other treatments.
This study tests a new way to treat common warts by injecting vitamin D directly into the wart. It may help your immune system clear the warts with minimal side effects.
This Phase 2 study tests giving a Candida antigen plus a bivalent HPV vaccine to help shrink or clear multiple common skin warts. It may help people with warts on different body areas, with different sizes or how long they’ve had them.
This trial tests a medicated liquid called cantharidin for treating common warts on the body (not on the face, soles, or private areas). The liquid is painted on by a doctor and later removed, and the goal is to see if it clears warts safely.
This trial tests a medication called cantharidin for treating common warts. It is for people age 2 and older who are generally healthy and have at least one common wart on the body (but not on palms, soles, face, or genitals). Participants cannot use other wart treatments during the study.
Hear when a new Common Wart trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.